Ultimately, in the age of personalized medicine, the integration of cutaneous microbiome signatures and comprehensive disease and drug response endotypes will herald a novel approach in the clinical management of chronic multisystem inflammatory diseases.
Sébastien Fromentin, Sofia K. Forslund, Kanta Chechi, Judith Aron‐Wisnewsky, Rima Chakaroun, Trine Nielsen, Valentina Tremaroli, Boyang Ji, Edi Prifti, Antonis Myridakis, Julien Chilloux, Petros Andrikopoulos, Yong Fan, Michael Olanipekun, Renato Alves, Solia Adiouch, Noam Bar, Yeela Talmor‐Barkan, Eugeni Belda, Robert Caesar, Luís Pedro Coelho, Gwen Falony, Soraya Fellahi, Pilar Galán, Nathalie Galleron, Gérard Helft, Lesley Hoyles, Richard Isnard, Emmanuelle Le Chatelier, Hanna Julienne, Lisa Olsson, Helle Pedersen, Nicolas Pons, Benoît Quinquis, Christine Rouault, Hugo Roume, Joe‐Elie Salem, Thomas Schmidt, Sara Vieira‐Silva, Peishun Li, Maria Zimmermann‐Kogadeeva, Christian Lewinter, Nadja B. Søndertoft, Tue H. Hansen, Dominique Gauguier, Jens Peter Gøtze, Lars Køber, Ran Kornowski, Henrik Vestergaard, Torben Hansen, Jean‐Daniel Zucker, Serge Hercberg, Ivica Letunić, Fredrik Bäckhed, Jean‐Michel Oppert, Jens Nielsen, Jeroen Raes, Peer Bork, Michael Stümvoll, Eran Segal, Karine Clément, Marc‐Emmanuel Dumas, S. Dusko Ehrlich, Oluf Pedersen
A. Rider, Henry J. Grantham, Graham R. Smith, David Watson, John Casement, Simon Cockell, Jack Gisby, Amy Foulkes, Rafael Henkin, Wasim Iqbal, Tom Ewen, Shoba Amarnath, Sandra Ng, Paolo Zuliani, Nick Dand, Deborah Stocken, Christopher Traini, E Thomas, Shanker Kalyana‐Sundaram, Deepak K. Rajpal, Kathleen M. Smith, Juliet N. Barker, Christopher Em Griffiths,
.webp)
Discussion(0)
No comments yet. Be the first to comment.